Importantly, genetic deletion of COX-2 prevented the stroke-induced loss of these critical structural proteins of the BBB and post-ischemic treatment with CAY10404 also significantly reduced the TJPs breakdown. This evidence concerns the gene PTGS2 and stroke disorder.